A Crispr Cure?

The transcript discusses the development and challenges of CRISPR-based drugs, highlighting the timelines for clinical trials, the technical and manufacturing hurdles, and the ethical considerations involved. It also covers the public and regulatory scrutiny of CRISPR, the business models being adopted, and the economic implications of gene editing technologies.

What are the implications of CRISPR technology being featured in popular media?

How does the company plan to address the unmet medical needs of patients through gene editing?

How does the company differentiate its gene editing technologies from existing methods?

What role do centers of excellence play in the delivery of gene editing therapies?